In advanced dementia, goals of care decisions are challenging and medical care is often more intensive than desired.
Background
Alzheimer disease and related dementias are a cause of functional dependency and death. Over 5 million Americans have dementia, and 1 million have advanced disease with loss of meaningful communication and total functional dependency. 1 Medical complications include nutritional problems, infections, and falls. Median survival in these patients is 1.3 years. 2 Family members make difficult choices on behalf of persons with dementia. Common decisions include resuscitation, tube feeding, treatment of infections, and hospital transfer. 3 Decisions are made in nursing homes, where 67% of persons with dementia die. 4 Families report limited communication and support for these choices. 5 , 6 The CASCADE study followed 323 nursing home residents with advanced dementia for 18 months. Only 38% of decision makers recalled involvement in treatment choices. Half spent less than 15 minutes discussing advance directives, and limited understanding was associated with more aggressive treatment. 2, 3 Treatments should align with medical goals such as survival, function, or comfort. 7 Shared decision making helps patients and families prioritize goals to guide treatment. 8 Decision aids improve shared decision making by informing and framing health care choices. 9 However, few decision aids are designed for dementia. [10] [11] [12] To address this gap we developed the Goals of Care (GOC) intervention, consisting of a video decision aid and structured care plan meeting for family decision makers for persons with advanced dementia. Our primary aim was to learn if the GOC intervention improves quality of communication and decision-making. Our second aim was to test whether the intervention would improve palliative care for advanced dementia.
Methods

Trial Design
The study was a single-blind cluster randomized trial of the GOC intervention compared with an attention control. Nursing homes were randomized to minimize contamination and parallel how decision aids are implemented. Outcomes were assessed at the level of the resident-family dyad. The University of North Carolina institutional review board approved the protocol (Supplement 1) prior to initiation of research, and 2 data safety monitors reviewed procedures and preliminary data every 6 months. Family decision makers provided written informed consent for themselves and the resident with advanced dementia. Family decision makers were compensated for their participation.
Randomization of Nursing Home Sites
Nursing homes were eligible within a 60-minute driving radius of the University of North Carolina-Chapel Hill. Administrators and medical directors agreed to site participation, and treating physicians gave permission to recruit families. The study statistician (F.-C.L.) randomized 22 nursing homes in blocks of 4, except for a final block of 2, matched by profit vs nonprofit status and percent African American residents.
Participants
From April 2012 to September 2014 we enrolled dyads of persons with advanced dementia and family decision makers. Nursing homes sent initial letters and referred those who agreed to contact with researchers. Residents were eligible if they were aged 65 years or older, had severe to advanced dementia, and had an English-speaking family decision maker. Nurses verified dementia stage (5-7 on the Global Deterioration Scale [GDS] ). 13 Persons with GDS 5 dementia cannot live independently and are frequently disoriented, while those with GDS 7 have sparse speech, dependency for all activities, and cannot recognize family. Family decision makers were eligible if they were legally authorized representatives for health care decisions as guardian, possessed health care power of attorney, or the decision maker under North Carolina law was sequenced as spouse, adult children, or sibling.
Intervention and Control
Intervention decision makers had the 2-part intervention, consisting of an 18-minute GOC video decision aid and a structured discussion with the nursing home care team. The decision aid was developed using International Patient Decision Aid Standards, and tested for feasibility and acceptability. 14, 15 It provided information on dementia, goals of prolonging life, supporting function, or improving comfort, treatments consistent with each goal, and how to prioritize goals. Decision makers saw the decision aid with research staff during their initial study visit, and received a print copy of the decision aid and guide called "Questions to Consider in Care Planning" (available on request from the authors).
To prepare staff for a goals of care discussion, investigators gave a 1-hour training session to nurses, social workers, therapists, and nutritionists who create care plans. They viewed the GOC decision aid, learned the VALUE (value family comments, address emotions, listen, understand the patient as a person, and elicit family questions) principles for family communication, and observed a short role play of a goals of care discussion. 16 Research staff also provided them with a Family decision makers in control sites experienced an informational video on interaction with someone with dementia and a usual care plan meeting with staff. Nursing home staff received a 45-minute training on study procedures. All other procedures were identical for both arms.
Data Collection
Research assistants blinded to participant assignment assessed outcomes. They interviewed family decision makers in person at baseline, and by telephone at 3, 6, and 9 months. They also completed structured resident medical chart reviews at baseline, and at 3, 6, and 9 months. On a resident's death, interviews were modified to address care during dying.
Family provided data about age, sex, race, education, and relationship for themselves and the person with dementia. Medical chart reviews provided data to calculate the Advanced Dementia Prognostic Tool (ADEPT), derived from standardized variables in nursing home records. The ADEPT scores range from 1 to 32.5, with higher scores indicating higher mortality risk. 18 Medical chart reviews were also the source of data on treatment in domains of palliative care, hospice enrollment, and transfers to emergency departments or hospitals.
Outcomes
Primary and secondary outcomes were compared at 3 months, 6 months, and a final end point of 9 months or death. Study outcomes for the primary aim were 3 familyrated measures of quality of communication and decision making at 3 months: (1) Quality of Communication (QOC) scores for nursing home staff, (2) concordance with clinicians on goals of care, and (3) the Advance Care Planning problem score. The valid and reliable QOC questionnaire is a 13-item instrument with an overall score and 2 subscale scores for "general communication skills" and "communication about end-of-life care." 19 Scores range from 0 ("poor") to 10 ("absolutely perfect"); responses of "clinician did not do" are recoded 0. To measure concordance with clinicians on the primary goal of care, family decision makers reported whether prolonging life, supporting function, or improving comfort was the "best goal to guide the resident's care and medical treatment," and separately reported which goal was the nursing home staff and physician's "top priority for the resident's care and medical treatment." Concordance meant the same response to both items. Finally, the Advance Care Planning Problem score was used to measure use of resident preferences to guide treatment. 20, 21 Three dichotomous items ask family decision makers if the resident's preferences were discussed, used to guide treatment, and if treatment was consistent with preferences. The score is reported as percent with 1 or more unfavorable responses. Secondary outcomes measured quality of palliative care at 6 months and at 9 months or death. Families rated quality of symptom management and overall care using the validated Symptom Management at the End of Life in Dementia (SM-EOLD) and Satisfaction with Care at the End of Life in Dementia (SWC-EOLD) instruments. The SM-EOLD ranges from 0 to 45 and the SWC-EOLD ranges from 10 to 40, with higher scores indicating better quality. 22 Investigators developed a Palliative Care Treatment Plan Domain score to capture the palliative care content of residents' treatment plans. Scores range from 0 to 10, with 1 point assigned when each of the following domains was addressed in the written care plan: prognosis, goals of care, treatment for physical symptoms, emotional needs, spiritual needs, and decisions to use or avoid use of 5 treatments: resuscitation, artificial feeding, intravenous fluids, antibiotics, and hospitalization. Research assistants completed paired medical chart reviews until they achieved an inter-rater reliability of greater than 0.85 on all items. To describe additional details of the treatment plan, research assistants also recorded do not resuscitate orders, orders not to hospitalize or use tube feeding, and completion of a Medical Orders for Scope of Treatment (MOST), the North Carolina version of the Physician Orders for Life Sustaining Treatment (POLST) order set. Medical chart reviews recorded hospice enrollment, hospital transfers, and resident deaths.
Statistical Analysis
Resident-family dyads were the primary unit of analysis, and all analyses used intention-to-treat assignment. Participants in the intervention and control groups were compared on baseline characteristics to explore possible between-group differences despite cluster randomized. Nursing home characteristics were compared using χ 2 tests for categorical variables and t tests for continuous variables. Intervention and control dyads were compared on primary and secondary outcomes measured at 3 months, 6 months, and at the final time point of 9 months or death. Rates of hospital or emergency department transfer were calculated as events per person-day at risk, to account for differential follow-up owing to death. In the longitudinal analysis, intraclass correlations were considered at 2 levels: residents clustered within nursing homes, and repeated measures for the same individual over time. Investigators fit a generalized mixed effects model with both a random intercept and random slope (in time) to control for the variation between nursing homes and correlation among residents within nursing homes, with treatment, time and interaction between treatment and time as covariates. Time was included as a categorical variable. They fit a simpler random intercept model with adjustment for baseline measures for the final 9-month or death outcomes and a fixed effects model with robust variance estimation when the random intercept model did not converge. Resident survival times were analyzed using Cox proportional hazards models for comparison between intervention and control groups, adjusted for nursing home cluster effects. All of the analyses used SAS statistical software (version 9.3, SAS institute) and P values less than .05 were considered significant.
With a sample size of 300 dyads, the trial was powered to detect a 0.8 mean difference in the overall QOC score, and a 1.5 mean difference in the QOC end-of-life subscale score be-Administrators and all physicians agreed to participate in 22 of 25 nursing homes approached. These 22 sites were paired and randomly assigned to intervention or control groups; sites did not differ in organizational characteristics (eTable A in Supplement 2). Nursing home staff identified 534 potentially eligible dyads; of these 118 (22%) decision makers refused contact, and 27 (5%) could not be reached. Of the 387 eligible family decision makers contacted, 302 (78%) agreed to participate and were enrolled. Accounting for expected deaths, participation was 99% complete at 3 and 6 months, and 100% at 9 months ( Figure 1 ).
Participant Characteristics
Residents with dementia had a mean age of 86.5 years, 246 (81.5%) were women, and they had a 12-month mortality risk of 33% based on ADEPT ( Table 1) . Family decision makers' mean age was 63 years, and most were daughters or daughtersin-law. Characteristics did not differ between study arms.
Communication and Decision-Making Outcomes
With the GOC intervention, family decision makers reported better overall scores on the 10-point QOC questionnaire at 3 months compared with those in the control group (6.0 vs 5.6, P = .05) ( Table 2) . Improvement corresponded to higher ratings of end-of-life communication (QOC end-of-life subscale, 3. 7vs3. 0;P = .02). The intervention group continued to report better quality end-of-life communication compared with controls in the final time period (QOC end-of-life subscale, 3.9 vs 3.1; P = .03), despite somewhat less positive ratings of general communication (QOC general subscale, 8.2 vs 8.6; P = .03). Compared with controls, family decision makers with the GOC intervention perceived greater concordance with providers regarding the primary goal of care by the final assessment (88.4% vs 71.2%, P = .001); concordance showed a trend favoring the intervention at 3 months. Comfort was increasingly the primary goal of care over time for both groups. Intervention and control decision makers did not differ on Advance Care Planning Problem scores. Examining individual items in this score, over 90% of decision makers in both groups reported treatment was consistent with resident preferences, but that discussion of residents' preferences to guide treatment was relatively infrequent (eTable B in Supplement 2). Family often discussed medical treatment choices with nurses or social workers, and a minority reported communication with nursing home physicians or nurse practitioners.
Quality of Palliative Care Outcomes
Family ratings of symptom management (SM-EOLD) and satisfaction with care (SWC-EOLD) did not differ between groups (Table 3) . However, following the intervention residents had more palliative care domains addressed in their treatment plans by 6 months, compared with residents in the control group (5.6 Copyright 2017 American Medical Association. All rights reserved.
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vs 4.7, P = .02). The most directly related domain-goals of care documentation-increased at 6 months (91% vs 42%, P < .001), and at the final assessment (95% vs 52%, P < .001).
Nursing home physicians or nurse practitioners completed a MOST order set more often for residents in the intervention group (35% vs 16%, P = .05). Do not resuscitate (DNR) orders were common, although somewhat less common in the intervention group (85% vs 91%, P = .04). During 9 months follow-up there were 33 hospital or emergency transfers in the intervention group and 67 in the control group. Adjusting for person-days at risk, residents in the intervention group were half as likely to experience hospital transfers (0.078 vs 0.163 transfers per 90 person-days; RR, 0.47; 95% CI, 0.26-0.88). During 9 months follow-up, 33 (22%) control residents and 27 (18%) intervention residents died; survival time did not differ significantly (hazard ratio [HR], 0.76; 95% CI, 0.54-1.08; P = .13) (Figure 2 ).
Discussion
The GOC decision aid intervention was effective to improve quality of communication about end-of-life care for nursing home residents with advanced dementia. Over time, family decision makers in both arms increasingly chose comfort as the primary goal of care, but those with the GOC intervention experienced better communication and enhanced confidence that health care providers were prioritizing the same goal. They typically communicated with nurses or social workers, not physicians, reflecting current roles in nursing home care.
These study outcomes are aligned with widely endorsed measures of quality palliative care. 23 Though improvements in quality of communication were modest, they were followed by greater attention to palliative care in treatment plans. The GOC intervention resulted in increased use of MOST to record goals of care and treatment choices. Though the intervention did not explicitly promote its use, the GOC intervention is consistent with MOST and may make it easier to introduce. This GOC study provides the first evidence that a decision aid can be used to enhance implementation of the POLST paradigm. 24 The GOC intervention also resulted in half as many hospital transfers for nursing home residents with advanced dementia, without affecting survival. Residents in both study arms had severe underlying illness, but the GOC decision aid allowed families to consider options of hospitalization or care at the nursing home for acute illness. Hospital transfers were a secondary outcome, but the finding is important because persons with dementia have a high rate of transfers. 25 Transitional care interventions have excluded persons with dementia, and the GOC intervention provides initial evidence that this outcome can be improved. a SM-EOLD scores range from 0 to 45, with higher scores indicating better symptom management; SWC-EOLD scores range from 10 to 40, with higher scores indicating greater satisfaction with end-of-life care.
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b Palliative care domain score ranges from 0 to 10, with higher scores indicating a greater number of palliative care domains addressed in treatment plans.
c These variables are reported as cumulative probability. P values for the final time point are reported based on a robust variance procedure owing to nonconvergance of the random intercept model. Abbreviation: QOC, quality of communication.
a Quality of Communication scale and subscales range from 0 to 10, with higher scores indicating better quality of communication.
b Percent of decision makers reporting at least 1 problem with use of resident preferences to guide treatment on 3 items composing the score.
c Rates reflect "ever discussed" at baseline, and reflect the "past 3 months" during each follow-up time period. Results from the GOC intervention are promising, yet they highlight elements of dementia palliative care that are in need of improvement. Family ratings of end-of-life communication improved, yet remained lower than QOC scores in intensive care units. 27 While communication with nursing home staff was common, only 1 in 4 family decision makers talked with physicians. Lack of physician communication may account for continued gaps in the quality of end-of-life communication. Further, ratings of symptom management and care were fairly good, but unchanged. The GOC intervention addresses shared decision-making, but targeted interventions are needed to improve symptoms and comfort in patients with dementia.
The GOC study was an efficacy trial, but the intervention was designed for practical implementation in nursing homes. 28 The video decision aid made evidence-based information easily accessible. After brief training, nursing home staff used a print guide to conduct all goals of care discussions. Further, the study was conducted in a diverse group of nursing homes, increasing potential for broad use. Finally, the intervention was designed to support shared decision making in a setting with limited physician presence, and to integrate with the national standardized care planning process for nursing home residents. 29 The research was completed prior to Medicare reimbursement for advance care planning communication, but this policy change may enhance physician involvement in the future.
Limitations
Findings should be interpreted in the context of study limitations. Although sites had diverse characteristics, all were within a single state. Characteristics match national data on nursing homes, but the GOC intervention could be more or less effective in other regions. The GOC framework was chosen for its relevance to shared decision making in dementia care. 30, 31 Alternative frameworks may be as or more useful to guide family decision makers. Interview questions about goals of care may have prompted some control families to seek discussions with nursing home clinicians, thus reducing measured effects of the intervention. Study findings apply to a long-stay population of residents who live in the nursing home, but should not be generalized to the short-stay rehabilitation population. The GOC intervention was designed to rely on existing communication skills and strategies used in nursing homes. This study is the first randomized clinical trial to address dementia palliative care needs in nursing homes, and future research is needed to expand on these results. Less pragmatic, but potentially higher impact interventions could include communication skills training for staff, specialty palliative care consultation, or payment reform to engage physicians and nurse practitioners as active participants in interdisciplinary teams in nursing home care.
Conclusions
The GOC decision aid intervention was effective to improve quality of communication for nursing home residents with advanced dementia, and to improve elements of palliative care. Hospital transfers were reduced for these frail patients, without any adverse effects on survival. The GOC study provides evidence for a promising new approach to enhance shared decision making for nursing home residents with advanced dementia and for their families. 
Protocol Introduction Background
Nursing home care is common in for persons with advanced dementia and 67% die in this setting. Dying residents have high rates of pain, dyspnea, problems with personal cleanliness, and emotional distress. Family decision-makers express more dissatisfaction with communication and care in nursing homes than any other setting. Poor communication is a major practical barrier to improved care. 1, 2 One retrospective study found 71% of residents had resuscitation and 30% end-of-life hospitalization contrary to their preferences. 3 In the prospective CASCADE Study (Choices, Attitudes and Strategies for Care of Advanced Dementia), Mitchell followed 323 nursing home residents with advanced dementia and surrogates for 18 months. Only 38% of surrogates recalled involvement in medical decisions, and less discussion was associated with poor quality care. 4 5 Over 20 randomized trials show decision aids improve time efficiency and quality of decisionmaking by improving knowledge and reducing conflict for patients. 6, 7, 8, 9, 10 They influence treatment choices in studies of prostate cancer screening, hysterectomy, and genetic testing. 11, 12, 13 Two recent trials found video decision aids on advance care planning increased geriatric or oncology outpatients' interest in comfort care.
14,15
Decision support research has addressed key outpatient choices, yet many clinically and ethically significant decisions are made by surrogates who speak for seriously ill patients. 16 In intensive care, printed information and structured family meetings improve knowledge and reduce emotional distress. 17, 18, 19 Surrogates for persons with dementia experience similar caregiver stress and anticipatory grief, yet the nature of this illness requires them to make health care decisions for years. 20 We completed the first randomized trial of a decision aid intervention for surrogates, addressing the choice of feeding options in advanced dementia.
Use of the goals of care framework is endorsed in professional ethics and included in prominent national training curricula for end-of-life care. 21 Exploring and defining goals of care allows decisionmakers to 1) frame treatment choices based on ability to achieve goals, and 2) create care plans inclusive of treatments to promote chosen goals, not just treatments to be withheld. While a few studies establish its feasibility, no clinical trial translates this framework into practice. Dementia patients in a small qualitative study were able to select goals of care. 22 In a larger descriptive study, patients (50% vs. 16%) and their surrogates (44% vs. 13%) favored the goals of care approach to advance care planning over a treatment-based approach, and usually prioritized goals of function and comfort. 23 Physicians are able to discern a logical pattern of treatments related to goals.
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One pre-post study asked nursing home residents or surrogates to prioritize the goals of longevity, function, and comfort, and accept one of 5 care plans. Of 38 participants, 71% of residents and 88% of surrogates were willing to prioritize goals. 25 Another pre-post study of goals of care decision-making in a Program for All-inclusive Care of the Elderly site showed a temporal shift toward prioritizing palliation. 26 These studies show the feasibility and promise of goals of care interventions.
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Study Aims
Family decision-makers in intervention sites will receive a decision support intervention with two components: a decision aid followed by a structured interdisciplinary care plan meeting. The control decision-makers will view a video about dementia care of similar length, and participate in routine nursing home care planning. An attention control condition was chosen to ensure that the content of decision support, and not simply additional interpersonal attention, is tested. The overarching objective is to test whether decision support for Goals of Care can improve quality of communication and decision-making, and improve the quality of palliative care for nursing home residents with advanced dementia. 
Methods
Study design
Initial research, including our own, demonstrates the acceptability and feasibility of goals of care decision support for surrogate decision-makers for persons with dementia. We propose a cluster randomized trial to test a decision support intervention for Goals of Care in advanced dementia. Family decision-makers in intervention sites will receive a decision support intervention with two components: a decision aid followed by a structured interdisciplinary care plan meeting. The control decision-makers will view a video about dementia care of similar length, and participate in routine nursing home care planning.
Study setting
Study subjects will be recruited in 20 skilled nursing facilities in North Carolina, varied in size, profit status, and diversity of residents. We expect 23 eligible resident-surrogate dyads per site. We expect to enroll 65-69% of those eligible, or 15-16 dyads per site, to reach 300 participants.
Participant Eligibility
Study subjects will be 300 residents with advanced dementia and their surrogates. Enrollment criteria are associated with 6-month mortality risk of 28%, resulting in clinical triggers to utilize Goals of Care to frame specific treatment decisions.
 INCLUSION: Nursing home residents with "moderate to severe dementia" o Age 65+ o Diagnosis of dementia o Score 5, 6 or 7 on GDS (update GDS every 3 months) 27 o Surrogates who are the LAR -guardian, Health Care Power of Attorney, or the usual family surrogate decision-maker identified by the face sheet in the chart. The decision maker may live out of the local area, but must speak English. o Hospice enrollees are included, MOST participants are included; Hospice is invited to Care Plan meeting for study participants  EXCLUSION: patients whose surrogate is a court appointed guardian who is a non-family member.  EXCLUSION: participants from the NPCRC Goals of Care pilot will not be eligible.
Intervention and Control
The 2-part intervention consists of the Goals of Care Decision Aid and a structured care plan meeting to discuss goals of care. During their baseline interview, intervention surrogates will view the audiovisual Goals of Care Decision Aid, covering content on dementia, goals of care, treatment approaches to expect with each choice, and personal goals. It concludes with prompts to talk with treating physicians, and "Questions to Consider in Care Planning." During viewing of the Decision Aid, Research Assistants will be present but will not discuss or add information. Within a few weeks _________________________________________________ Goals of Care NIA June 6, 2013 page 5 intervention surrogates will be invited to the structured Goals of Care meeting with the interdisciplinary team. The meeting protocol uses the "VALUE" principles for family meetings, addresses the role of the surrogate, answers questions on health status and examines goals and a related treatment plan. Treating physicians, nurse practitioners or physician's assistants will be encouraged but not expected to attend. They will receive a copy of the Goals of Care plan and must approve any changes in orders. The team will allow 30-60 minutes for this meeting, consistent with usual meetings for a change in health status.
We will use an attention control condition. During their baseline interview, control surrogates will view an informational video on ways to interact with dementia patients, with content on dementia, its causes and stages, and stage-specific ways a family caregiver can communicate with and engage the person with dementia. 28 This control is relevant to surrogates but neutral for outcomes. Research Assistants will be present but will not add information. Within 2 weeks control surrogates will be invited to usual care plan meetings with the interdisciplinary team. All other aspects of study participation will be identical.
Fidelity Assessment
INTERVENTION: Completed Care Plan Guide data will be collected on all meetings
o May be completed by telephone with liaison / IDT leader o A random 10% sample of INTERVENTION care plan meetings will be audio-recorded to add data on fidelity.  Core: Fidelity to the intervention -sites must meet this criterion for 70+% of participants 1. Surrogate reviews DA (Baseline interview) 2. Surrogate participated in meeting, and asked for input on treatments within 3 months; can occur outside the usual care plan meeting schedule; at least 2 disciplines from staff must participate (Guide; use 3 month interview as back-up source)  Descriptive: Quality of the intervention 1. Components of the meeting -health status, goals discussed, choice of goal, treatment plan confirmed or changed (Guide; use 3 month interview as back-up source) 2. Participation by MD / NP / PA providers (Guide) 3. Quality of communication with care plan team -VALUE items (3 / 6 month interviews) 4. Documentation of the meeting -discussion of goals, setting a primary goal, treatment decisions confirmed or made (3 / 6 month chart reviews) 5. Audiotapes of 10% of meetings -confirmation of components of the meeting (tape transcript vs. Guide)
Outcome Measures
Primary Outcome Measures Aim 1 • Quality of Communication will be measured interviews using the Quality of Communication (QOC) instrument. 29 Respondents rate 13 items on a 10-point scale, to give potential scores ranging from 0 ("very worst") to10 ("very best"). A score of 0 is imputed for no communication; missing values are imputed to the median. Summary scores are generated as the mean score of all items; a separate item rates communication overall. The QOC has convergent validity with measures of _________________________________________________ Goals of Care NIA June 6, 2013 page 6 overall communication and understanding; it has been used in research on family meetings. 30 Items form two subscales measuring general (Cronbach's alpha=0.91) and end-of-life communication (Cronbach's alpha=0.79).
• Health care provider-surrogate concordance on goals of care will be defined as the percent of surrogates that report a primary goal (comfort, function, survival, other) the same as the primary goal for providers. At each Follow-up Interview, surrogates will be asked; "The most common medical goals for treatment are prolonging life, maintaining function, and improving comfort. Which goal would you say is the best goal to guide his / her care and medical treatments?" Response options include these three medical goals, "other" or "uncertain." They will also answer "Based on your discussions with the nursing home staff and physician, which of these goals is their top priority for his / her care and medical treatment?" • Treatment consistent with wishes will be measured using the Advance Care Planning problem score from the Toolkit Family Interview. 31 The Toolkit is a reliable and valid instrument based on a conceptual model of patient-focused, family centered end of life care. The Toolkit includes "problem scores" for domains of care; each problem score is valid for independent use. 32, 33 The Advance Care Planning problem score consists of 3 items assigned one desired answer; a "problem score" is calculated as percent of respondents giving a non-desired answer to one item:
1. Did RESIDENT's doctor or the nursing home staff who care for him / her speak to you about his / her wishes about medical treatment? (YES / NO) 2. Did his / her doctor or the nursing home staff who care for him / her speak to you about making sure his / her care was consistent with his / her wishes? (YES / NO) 3. Since I last spoke with you, was there any medical procedure or treatment that happened to him / her that was inconsistent with his / her previous wishes? (YES / NO) • Combined results for these three measures are identified as the primary study outcome for clinical trial registration (Clinicaltrials.gov NCT 01565642, 3/26/12)
Outcome Measures Aim 2
• Number of palliative care domains addressed for resident plan of care will be measured by reviewing the relevant Care Plan at each time point for content in 10 domains of palliative care --prognosis, goals of care, plan for physical symptoms, plan for emotional needs, plan for spiritual needs, and 5 treatment preferences: resuscitation, artificial feeding, intravenous fluids, antibiotics, and hospitalization. Since the goal of the intervention is to improve shared decision-making regardless of treatment choice, domains will be scored on whether they are addressed; not choice for or against a treatment. Each domain will be scored as present or absent for a potential score of 0-10. For example, a point will be given if resuscitation was addressed, regardless of a choice for or against. We estimate a baseline score of 2 domains.
• Symptom Management will be measured using the Symptom Management at the End of Life in Dementia (SM-EOLD) instrument, developed and validated concurrently with the SWC-EOLD and CAD-EOLD below. This instrument measures symptom control for 6 psychological and 3 physical symptoms common in advanced dementia. Items are rated on a 0-5 categorical scale and summed, for a total potential score of 0-45. This instrument has good internal consistency (Cronbach's alpha 0.68 to 0.78) and convergent validity with a quality of life measure for dementia. Originally designed for after-death interviews, it has been successfully modified for use in a prospective cohort study of advanced dementia care. • Quality of Dying in Long-term Care (QOD-LTC) -This instrument (Cronbach's alpha = 0.66) measures the family surrogate's perception of the quality of the dying experience; it will be measured in After Death Interviews. This 11-item instrument has 3 subscales measuring personhood, closure and preparatory tasks before dying. Items are rated on a 5-point scale for a total potential score of 5-55. 39 • Frequency of communication will be defined as the number of discussions of goals of care with providers reported by surrogates after each follow-up interval. Communication with physician, nurse practitioner, physician assistant, or nursing home staff will be rated 0-1 and summed (range 0-3). Communication with physicians in hospital will be described but not counted, as it is dependent on use of hospitalization.
• Hospice referral will be measured by recording presence and date of referral from Chart Reviews.
• Hospitalizations will be measured by recording the rationale and date from Chart Reviews.
Randomization
 Matching and randomization of sites in blocks of size 4, matched by profit / non-profit, percent African-American.  Study biostatistician randomizes sites using computerized random number generation 
Sample Size
We have an adequate sample necessary to detect clinically meaningful differences between intervention and control conditions for our primary outcomes. Statistical power is shown based on 2-sided alpha of 0.05 significant tests, and using standard deviation estimates from published measures (3.4.f.) adjusting for correlation among respondents within nursing homes. Power calculations are corrected for anticipated dropout and potential non-independence of observations within the 20 nursing homes (clusters), using potential intra-class correlations of 0.01, and 0.05, based on observed intra-class correlation in our prior work. As an example, for the number of palliative care domains for Aim 2a, we expect 95% power to see at least a 2 point improvement in the intervention arm compared to the control group at six months, and 79% power after death, based on an intra-class correlation of 0.01. We did not calculate power for the outcome concordance on goals of care since it is not a standardized measure. Power to detect clinically meaningful differences is excellent and 3 and 6 months, and good after death. and HIPPA authorizations at the facility.  Set up secondary meetings after randomization at 20 nursing home sites to review study procedures o INTERVENTION: At intervention sites only, the second meeting introduces the care plan team and other facility staff to recruitment, data collection procedures, and the nature of the intervention. Participants see the Goals of Care decision aid, learn about the "VALUE" principle approach, and are taught to use the "Care Plan Guide" to guide and record the GOC care plan meeting. They are encouraged to consider use of sample goaldirected care plans, MD communication care to promote MD role, and specialized documentation (e.g. MOST) to record decisions made in the meeting. o CONTROL: At control sites only, the second meeting introduces the care plan team and other facility staff to recruitment, data collection procedures, and the attention control video. Care plan meetings will continue as usual in the control sites.
 Each nursing home site will receive a $250 incentive for each quarter they are able to successfully recruit subjects or up to a $1000 incentive per site.
Provider Approval and Engagement
 The Medical Director is contacted by the PI or other MD investigator to review the study and give approval for participation. Physician investigators introduce the study to each treating physician, NP or PA by telephone; they also offer to meet face-to-face or to share a 1-page summary by the providers' preferred method of contact.  All MD, NP, and PA providers with eligible residents are contacted by the PI or other MD investigator to review the study and give approval for participation by their residents and families. o INTERVENTION ONLY: MD, NP and PA providers receive a written notice of the GOC Care Plan meeting time and location; notice may be given before the meeting (if the provider plans to attend) or after (if the provider prefers to follow-up later); providers with enrolled residents and families are given a time-limited option to view the GOC Decision Aid. 
Recruitment of Subjects
 Retrieve names of potential subjects from nursing home liaison, identifying residents with probable moderate to severe dementia. Initial screening may include MDS C1000=2,3 for impaired decision-making for efficiency in sites with electronic access to the MDS. Initial screening may also include talking with primary nurses about their residents using the GDS.  Use a HIPPA waiver to conduct a screening chart review of nursing home record. Residents who are 65+, have a diagnosis of dementia , and a moderate to advanced dementia score of a 5, 6 or 7 on the Global Deterioration Scale (GDS) per the resident's primary nurse, and a valid surrogate are eligible. o Defined data tracking used for refusals to ensure generalizability  Update the GDS score review every 3 months  Recruiting letters come from the nursing home; cover letter or recruiting letter on NH letterhead (NIH requirement).  Send recruiting letters 6 weeks or more before their scheduled care plan meeting to give time for the baseline interview to occur before the meeting.  Allow 7-10 days to pass after recruiting letters are mailed, and then begin recruiting calls.  Have a toll free number on recruiting letter and an opt out card for decision makers to mail in if they do not want to receive a recruiting call.  Recruiting calls can permit decision-makers time to decide; if currently stressed or with competing time demands, they may delay the decision to participate until a later date.
Data Collection: Nursing Home Organizational Variables
 Each participating nursing home liaison completes a short data form with variables describing the nursing home site and the resident population it serves; data includes organizational characteristics, resident descriptors, current use of MOST, Hospice contract, and any specialized on-site palliative care approaches or services; LTC Focus site and NH Compare can be used to abstract some of this data.
Baseline Data Collection
 Complete written informed consent and baseline interview in person; subjects will be paid $35 for the baseline interview. o INTERVENTION subjects will view the Goals of Care video decision aid o INTERVENTION subjects will receive a paper copy of the decision aid and a Care Plan Guide to further review and to share with other family members involved in the decision making process. o CONTROL subjects will view the dementia informational video o Families whose usual decision-making approach is to include more than one surrogate will be allowed to include other family members in the interviews; however, the primary decision-maker will be the unique research participant and will take final responsibility for interview responses. The total number of additional participants will be recorded as a variable. reviewed either by DVD or online through www.vimeo.com depending on ease of use and internet access. A link to the decision aid will be emailed to those opting to view the decision aid online. This link is password protected, and the password will be changed after each interview. The DVD, with explicit directives to wait for instructions from the interviewer before viewing, will be mailed to those preferring that option.  Complete a full baseline chart review at the time of enrollment.  Measurement of communication / treatment in 10 palliative care domains including prognosis, goals of care, plan to assess and treat physical symptoms, plan to assess and meet emotional needs, plan to assess and meet spiritual needs, and preferences for use of 5 treatments: resuscitation, artificial feeding, antibiotics, hospital transfers and hospice will be inclusive of evidence found in progress notes / orders / care plan. Training for each data collector will specifically include testing of inter-rater reliability for this variable, as it is constructed uniquely for this study.
Care Plan Meeting
 In INTERVENTION sites, the next quarterly care plan meeting, or special meeting for "change in health status" outside the care plan schedule will be scheduled with invitations to the surrogate, the IDT, and the treating MD, NP or PA. o This meeting may be a "special" meeting or part of the routine care plan meeting schedule, but must include at least 2 disciplines o MD, NP or PA providers will receive written notice of the meeting beforehand, or after if they do not plan to attend (see MD LETTER) o The staff liaison will complete the Care Plan Meeting Guide after the meeting, to provide fidelity data o The staff liaison will be encouraged, but not required, to provide the treating MD, NP or PA with information regarding the surrogate's need for further communication and discussion of treatment options (see MD / NP / PA Communication)  In CONTROL sites, care plan meetings will be scheduled as usual.  During and after the care plan meeting, care plans and treatment decisions will remain completely controlled by the primary MD / NP / PA, the nursing home team, and the surrogate decision maker. interviews.  All chart reviews will also examine interval changes in health status and goals of care or treatments, and surrogate and MD / NP / PA provider presence at care plan.  9 month chart review: The 9 month chart review's window will extend one week outside of the due date to account for information that may be entered in the chart late.
Follow-Up Data Collection
 If the enrolled surrogate decision develops their own disabling illnesses or cognitive difficulties over the 9 month follow-up period, the facility liaison will be contacted to discuss how to proceed with the remaining follow-up interviews. If the facility is still considering the enrolled decision maker to be the legally authorized representative, the PI will determine if the followup interviews need to be suspended due to the decision maker's declining health or cognitive status. If the facility liaison indicates another family member is now the legally authorized representative, the new decision maker will be sent a letter of invitation. If this decision maker agrees to participate in the study, the interviews will begin with the Baseline interview with the new family decision maker. To test the effect of the Goals of Care decision support intervention on the quality of communication and decision-making, we will compare control and intervention groups on pre-specified outcomes; we will focus on 3 month data. 
Analysis to meet Aim 2
To test the effect of the GOC decision support intervention on quality of palliative care for residents with advanced dementia; we will focus on 6 month data. o Each domain scored present or absent, range 0-10  Scored on whether they are addressed, not choice for or against a treatment o 10 items: prognosis, goals of care, plan for physical symptoms, plan for emotional needs, plan for spiritual needs, resuscitation, artificial feeding, IV fluids, antibiotics, and hospitalization o Change scores will be created comparing 6 month scores to baseline  Subscale 5=Response to Surroundings (B30_7,B50_2, B50_3, B50_7)  0 assigned to responses which do not reflect a good quality of life  Higher numbers indicate higher quality of life  Step 1. Score each domain by summing the scale value (please refer to end of this document for scale values) assigned to the responses across items in that domain.  Step 2. Divide the total from Step 1 by the maximum total scale value for the domain.  Step 3. Multiple the result (or quotient) from Step 2 by 100 to obtain a percentage score ranging from 0 to 100.  To calculate an overall score for the ADRQL, sum the scale values assigned to the responses across all 40 items in the instrument and divide the sum by the maximum total scale value for the overall ADRQL, then multiple the quotient by 100 to obtain a percentage score. Table A. 2 lists the maximum total scale values for the 5 ADRQL domains and for the overall ADRQL that should be used  To score the ADRQL when one or more items are missing, subtract the scale value for each item that is missing from the maximum total scale value (see Table A .2). The resulting modified maximum total scale value should be used as the denominator in Step 2 of the scoring procedures described above.
•  E10, E50, E80=true,  E20, E30, E40, E60, E70=false  Number correct
